TREA

79345925 - SCT BIO

Follow

Information

  • Trademark
  • 79345925
  • Serial Number
    79345925
  • Registration Number
    7238443
  • Filing Date
    April 14, 2022
    3 years ago
  • Registration Date
    December 12, 2023
    a year ago
  • Transaction Date
    April 02, 2024
    a year ago
  • Status Date
    December 12, 2023
    a year ago
  • Published for Opposition Date
    September 26, 2023
    2 years ago
  • Location Date
    December 12, 2023
    a year ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    LUEKEN, ABIGAIL JOSEPH
  • Attorney Name
    Shane Rumbaugh
    Law Office Assigned Location Code
    L90
  • Owners
Information
Mark Drawing Code
5000
Mark Identification
SCT BIO
Case File Statements
  • GS0401: Manufacture of cell therapy materials, namely, autologous and allogenic cell-based therapy pharmaceuticals to the order and specification of others; manufacture of viral and non-viral vectors to the order and specification of others; manufacture of cellular vaccines, car-t therapy materials, namely, chimeric antigen receptor T cell-based pharmaceuticals, tcr-t therapy materials, namely, T cell receptor T cell-based pharmaceuticals, or car-nk therapy materials, namely, chimeric antigen receptor natural killer cell-based pharmaceuticals to the order and specification of others
  • DM0000: The mark consists of the stylized letters "SCT" in red followed by the stylized letters "BIO" in turquoise.
  • GS0391: Packaging services in the nature of applications of labels to cell therapy materials; storage and distribution of cell therapy materials
  • CC0000: The color(s) red and turquoise is/are claimed as a feature of the mark.
  • GS0421: Pharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; scientific research and development, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; consultation in the field of pharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; product research and development, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; biological materials testing services and biological laboratory services, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; contract research services in the field of cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies
Case File Event Statements
  • 4/2/2024 - a year ago
    35 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 3/13/2024 - a year ago
    34 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 3/13/2024 - a year ago
    33 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 3/12/2024 - a year ago
    32 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 2/16/2024 - a year ago
    31 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 2/16/2024 - a year ago
    30 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 2/16/2024 - a year ago
    29 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 12/12/2023 - a year ago
    28 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 12/12/2023 - a year ago
    27 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 9/26/2023 - 2 years ago
    26 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/26/2023 - 2 years ago
    25 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 9/25/2023 - 2 years ago
    24 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 9/6/2023 - 2 years ago
    23 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 9/6/2023 - 2 years ago
    22 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 9/6/2023 - 2 years ago
    21 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/24/2023 - 2 years ago
    20 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/23/2023 - 2 years ago
    19 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 8/23/2023 - 2 years ago
    18 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 8/23/2023 - 2 years ago
    17 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 8/23/2023 - 2 years ago
    16 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 7/20/2023 - 2 years ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/20/2023 - 2 years ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/20/2023 - 2 years ago
    13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/14/2023 - 2 years ago
    12 - REFUSAL PROCESSED BY IB Type: RFNT
  • 1/25/2023 - 2 years ago
    11 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 1/25/2023 - 2 years ago
    10 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 1/20/2023 - 2 years ago
    9 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 12/25/2022 - 2 years ago
    8 - CHANGE OF OWNER RECEIVED FROM IB Type: CHLD
  • 11/24/2022 - 2 years ago
    7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 11/23/2022 - 2 years ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/22/2022 - 2 years ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/18/2022 - 2 years ago
    4 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 8/2/2022 - 3 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 7/29/2022 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/28/2022 - 3 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR